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Abstract
Background: The human zinc finger protein 191 (ZNF191) is a member of the SCAN domain
family of Krüppel-like zinc finger transcription factors. ZNF191 shows 94% identity to its mouse
homologue zinc finger protein 191(Zfp191), which is the most highly conserved among the human-
mouse SCAN family member orthologues pairs. Zfp191 is widely expressed during early
embryogenesis and in adult organs. Moreover, Zfp191-/- embryos have been shown to be severely
retarded in development and die approximately at embryonic day E7.5. ZNF191 can specifically
interact with the widespread TCAT motif which constitutes the HUMTH01 microsatellite in the
tyrosine hydroxylase (TH) gene. Allelic variations of HUMTH01 have been stated to have a
quantitative silencing effect on TH gene expression and to correlate with quantitative and
qualitative changes in the binding by ZNF191. In addition, ZNF191 displays a suppressive effect on
the transcription; however, little downstream targets have identified.
Results:  We searched for ZNF191 target genes by using a transient overexpression and
knockdown strategy in the human embryo kidney (HEK293) cells. Microarray analyses identified
6094 genes modulated by overexpression of ZNF191 and 3332 genes regulated by knockdown of
ZNF191, using a threshold of 1.2-fold. Several interested candidate genes, validated by real time
RT-PCR, were correlated well with the array data. Interestingly, 1456 genes were identified in both
transient overexpression and transient knockdown strategies. The GenMAPP and MappFinder
software packages were further used for pathway analysis of these significantly altered genes.
Several gene pathways were found to be involved in processes of the regulation of kinase activity,
transcription, angiogenesis, brain development and response to DNA damage.
Conclusion: Our analysis reveals for the first time that ZNF191 is a pleiotropic factor that has a
role in hematopoiesis, brain development and cancers.
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Background
The regulation of gene expression in response to intrinsic
and extrinsic cues is a fundamental cellular process in the
growth and development of organisms. Critical to the
control of gene expression are transcription factors that
bind to specific DNA sequences and subsequently modu-
late gene transcription [1]. A significant number of tran-
scription factors use a conserved zinc finger domain to
bind their target DNAs. Zinc finger factors participate in a
variety of cellular activities, such as development and dif-
ferentiation, and play a role in human disease. In fact, the
human genome encompasses approximately 600 to700
genes that contain a particular C2H2-type of zinc finger,
which employs two cysteine and two histidine amino acid
residues to coordinate the single zinc atom in the finger-
like structure [2-4]. In the C2H2-type of zinc finger pro-
teins, there is a highly conserved consensus sequence
TGEKP(F/Y)X (X representing any amino acid) between
adjacent zinc finger motifs. The zinc finger proteins con-
taining this specific structure are termed Krüppel-like zinc
finger proteins because the structure was first found in
Drosophila Krüppel protein [5,6]. Many Krüppel-like fac-
tors exhibit diverse regulatory functions in cell growth,
proliferation, differentiation, and embryogenesis [7-10].
The SCAN (SRE-ZBP, Ctfin 51, AW-1, and Number 18)
[11,12], which is also known as the leucine rich region
(LeR) [12], KRAB (Krüppel-associated box) [10,13], and
POZ (poxvirus and zinc finger) [14] domains are highly
conserved modules found in the N-terminus of C2H2 zinc
finger transcription factors that have been demonstrated
to mediate specific protein-protein interactions [15-18].
The SCAN domain is a conserved motif that appears to
control the association of SCAN-containing proteins into
non-covalent complexes, and may be the primary mecha-
nism underlying partner choice in the dimerization of
these transcription factors [16,19-22]. The genes encoding
SCAN domains are clustered, often in tandem arrays, in
both the human and mouse genomes and are capable of
generating isoforms that may affect the function of family
members. Although the function of most of the family
members is not known, some of the SCAN domain family
members play roles in cell survival and differentiation or
development [16,23-25]. Like the KRAB motif, the SCAN
domain-containing C2H2 zinc finger proteins are unique
to the vertebrate lineage [2,3].
Human zinc finger protein 191 (ZNF191, also known as
ZNF24 and KOX(17) [10]) is a member of the SCAN
domain family of Krüppel-like zinc finger transcription
factors [15]. This gene is initially named as RSG-A (for
retinoic acid suppressed gene-A) because its mRNA can be
amplified by homologous RT-PCR only in retinoic acid-
untreated but not in retinoic acid-treated acute promyelo-
cytic leukemia NB4 cells[26]. ZNF191 shows 94% identity
to its mouse homologue zinc finger protein 191(Zfp191,
also called ZF-12), which is the most highly conserved
among the human-mouse SCAN family member ortho-
logues pairs[16]. Tissue mRNA analysis showed that
ZNF191  gene was ubiquitously expressed [26,27]. The
mouse  Zfp191  has been previously isolated from
chondrocytic and mesenchymal precursor cell lines using
a subtractive hybridization screening. Zfp191  mRNA is
expressed during embryonic development and in different
organs in adult, including rib cartilage, suggesting that
Zfp191 may have a role in cartilage differentiation and in
basic cellular processes[28].
A study demonstrated that ZNF191 can specifically bind
to the TCAT repeats (HUMTH01) in the first intron of the
human tyrosine hydroxylase (TH) gene, which encodes
the rate-limiting enzyme in the synthesis of catecho-
lamines [27,29]. Allelic variations of HUMTH01 have a
quantitative silencing effect on TH  gene expression in
vitro, and correlate with quantitative and qualitative
changes in the binding by ZNF191 [27]. ZNF191 mRNA
levels was present at high levels in catecholaminergic tis-
sues including the substantia nigra, the hypothalamus
and the olfactory bulb. In the rat embryo, the mRNA was
present at high levels in total embryonic head, which may
reflect a role in brain development [27]; however, the
molecular mechanisms remain unknown.
The  ZNF191  gene is located on chromosome
18q12.1[10,26], a region frequently deleted in colorectal
carcinomas, suggesting a possible role in the negative reg-
ulation of tumor growth[30,31]. ZNF191 contains four
continuous typical C2H2 zinc fingers in its C-terminus,
and one SCAN domain in its N-terminus [10,26]. Bio-
chemical binding study shows the SCAN domain of
ZNF191 as a selective oligomerization domain[20]. The
SCAN domain of ZNF191 displays a suppressive effect on
the transcription in CHO and NIH3T3 cells[26]; however,
little else is known regarding its role in gene expression.
In the present study, we transiently overexpressed and
silenced  ZNF191  gene in the human embryo kidney
(HEK293) cells and then applied microarray assay to
identify possible ZNF191 target genes. Expression of inter-
ested candidate genes was also examined by real time RT-
PCR, and these data correlated well with the array data. In
general, our data reveal that ZNF191 modulates the
expression of a large number of genes that are implicated
in regulation of kinase activity, regulation of transcrip-
tion, angiogenesis, brain development and response to
DNA damage. Our analysis reveals for the first time that
ZNF191 is a pleiotropic factor that has a role in hemat-
opoiesis, brain development, tumor growth.BMC Genomics 2009, 10:241 http://www.biomedcentral.com/1471-2164/10/241
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Results
Data analysis: general features
To identify ZNF191 target genes, a combined approach of
transient overexpression and transient knockdown (KD)
are used to identify genes modified by the ZNF191 tran-
scription factor with 44 K Whole-Genome 60-mer oligo-
nucleotide microarrays, using a cellular model (HEK293).
Plasmids overexpressing ZNF191  cDNA (pcDNA3-
ZNF191) or control empty pcDNA3 vectors were tran-
siently transfected into HEK293 cells for 24 hours. As
expected, introduction of pcDNA3-ZNF191 in HEK293
cells resulted in higher expression of ZNF191 mRNA than
in cells transfected with control empty plasmid or
untreated cells (Figure 1A). Real-time PCR results showed
that the ZNF191 expression level was increased > 30 times
in cells transfected with pcDNA3-ZNF191 compared with
control cells (Figure 1B). For the reduction of ZNF191
expression, three hairpin siRNA expression vectors against
ZNF191  were generated [32] and the knock-down of
ZNF191 was assessed 48 hours after transfection of the
HEK293 cells. Figure 2 showed that the three siRNA
expression vectors were found to efficiently eliminate the
target mRNA. The reduction of ZNF191 mRNA levels in
transfected cells appears to be approximately 60% at the
best compared to the control level. Due to no greater inhi-
bition of ZNF191 mRNA at longer times than 48 hours,
transfection of the HEK293 cells with the most efficient
vector for 48 h was used in subsequent experiments.
RNA samples were prepared from the transient overex-
pression and transient knockdown cells as well as control
cells. Probe labelling, hybridization, and scanning were
done by Shanghai Biochip Co., Ltd (China). The complete
list of genes with differential expression can be found at
the website http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE14273. Microarray showed that 3273
genes were up-regulated more than 1.2-fold, while 3631
were down-regulated by the overexpression of the
ZNF191 gene (see Additional file 1), while 2111 were up-
regulated by the KD and 1221 were down-regulated, using
the same threshold (see Additional file 2). Interestingly,
1456 genes were identified in both situations, and 1344
(92%) behaved consistently between the two experiments
(i.e. induced by the overexpression and repressed by the
KD, or the other way around) (see Additional file 3).
These identified genes were subsequently used in pathway
analysis with MappFinder.
Using a threshold of 2 for data analysis, 592 genes were
found to be regulated by the overexpression with 143
genes up-regulated and 449 down-regulated (see Addi-
tional file 1, highlighted data) while 172 genes were regu-
lated by the KD with 83 genes up-regulated and 89 down-
regulated (see Additional file 2, highlighted data). The
overlap was found between transient overexpression and
transient knockdown with 69 shared genes(see Additional
file 3, highlighted data). Thus, ZNF191 appears to modu-
RT-PCR analysis of the ZNF191 gene expression in HEK293 cells transfected with pcDNA3-ZNF191 or pcDNA3 and  untreated cells Figure 1
RT-PCR analysis of the ZNF191 gene expression in HEK293 cells transfected with pcDNA3-ZNF191 or 
pcDNA3 and untreated cells. (A) Semiquantitative RT-PCR analysis of the ZNF191 gene expression in the transfected cells 
and untreated cells. Total cellular RNA was isolated from pcDNA3-ZNF191 or pcDNA3 transfectants and untreated cells, and, 
after reverse transcription, PCR was performed with ZNF191- and GAPDH- specific primers. The up-regulation of the 481-bp 
ZNF191-specific band was detected in cells transfected with pcDNA3-ZNF191 plasmid. (B) Quantitative RT-PCR analysis of 
the relative ZNF191/GAPDH expression in the transfected cells and untreated cells.BMC Genomics 2009, 10:241 http://www.biomedcentral.com/1471-2164/10/241
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late multiple transcriptional events, acting both as an acti-
vator and a repressor.
Pathway analysis of the ZNF191 transient overexpression 
and knockdown signature
To further evaluate our microarray data, GenMAPP and
MAPPFinder software http://www.genmapp.org were
used to organize gene expression data into MAPPs (micro-
array pathway profiles) that represent specific biological
pathways and functionally grouped genes, based on the
GO system. Three main classes of branches in the GO tree
are biological processes, molecular functions and cellular
components [33].
We focused on microarray gene expression data of 1456
genes identified in both transient overexpression and
transient knockdown treatment. Using gene-association
files from the GO Consortium, MAPPFinder assigns the
thousands of genes in the dataset to numerous GO terms.
Our analysis was limited to the GO terms that comprise
more than eight genes in a class. Several significant (i.e., z
score > 2) functional MAPPs were revealed with MAPP-
Finder and were presented in Table 1. Gene pathways that
are involved in the regulation of kinase activity and angiogen-
esis were significantly up-regulated. In contrast, processes
associated with response to DNA damage stimulus and brain
development  were down-regulated. Many up-regulated
processes are localized to cellular component (endoplasmic
reticulum) while down-regulated processes belong
mainly to the cellular components (ribosome, extracellular
matrix and cytoplasmic membrane-bound vesicle). Figure
3, 4, 5 and 6 and Table 2 showed the ZNF191 overexpres-
sion and ZNF191  knockdown differentially expressed
genes involved in these signaling pathways.
Quantitative Real-Time RT-PCR
Twenty-one interested genes were selected and subjected
to real-time PCR analysis to confirm our microarrays
results. As shown in Figure 7, the direction of regulation
of ATP7A, RECK, PDGFRB, BMPR2, RB1, BRCA1, BRCA2,
ATM, ATRX, IFI16, CCNB2, MYO6, GADD45B, SEMA5A,
NRP2, CTGF, C5, VEGF, THBS1, KITLG and FOXP2
(expect for CCNB2) by the overexpression and knock-
down of ZNF191 was consistent with the microarray
results.
Discussion
In this study, we identify genes modified by the ZNF191
transcription factor with a combined strategy of transient
overexpression and transient knockdown (KD) in a cellu-
lar model (HEK293), using oligonucleotide microarray
technology. Several gene pathways were revealed by
MAPPfinder to be involved in processes of the regulation
of kinase activity, transcription, angiogenesis, brain devel-
opment and response to DNA damage.
Pathway of regulation of kinase activity was significantly
affected (Z-score 2.73). This pathway had a large number
RT-PCR analysis of the ZNF191 gene expression in HEK293 cells transfected with ZNF191 siRNA expression vectors or empty  plasmid Figure 2
RT-PCR analysis of the ZNF191 gene expression in HEK293 cells transfected with ZNF191 siRNA expression 
vectors or empty plasmid. (A) Semiquantitative RT-PCR analysis of the ZNF191 gene expression in the transfected cells. 
RT-PCR and gel electrophoresis of amplified products. The sizes of the amplified products are 481 bp (ZNF191) and 381 bp 
(GAPDH). Lane 1, the control cells (transfected with empty vector). Lane 2, lane 3, or lane 4, HEK293 cells transfected with 
pSZNF191-1, -2, or -3 (ZNF191 siRNA expression vectors), respectively. Lane 5, DNA size marker. (B) Quantitative RT-PCR 
analysis of the relative ZNF191/GAPDH expression in the transfected cells. Lane 1, the control cells (transfected with empty 
vector). Lane 2, lane 3, or lane 4, HEK293 cells transfected with pSZNF191-1, -2, or -3, respectively.BMC Genomics 2009, 10:241 http://www.biomedcentral.com/1471-2164/10/241
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of expression changes, mostly due to the regulation of 12
genes (GADD45B, SPRY4, DUSP6, RGS4, SPRED2, NRG1,
EDN1, CCNA1, CDKN2B, CKS1B, SERTAD1 and
DUSP6), which were up-regulated in the ZNF191-overex-
pressed cells and down-regulated in the ZNF191 knock-
down cells. In additional, 8 genes (KITLG, PKIA, RB1,
ZAK, PRKD3, C1QTNF6, C5 and MAP4K5) were down-
regulated in the ZNF191-overexpressed cells and up-regu-
lated in the ZNF191 knockdown cells. A map of the genes
involved in regulation of kinase activity was shown in Fig-
ure 3. GADD45B, originally termed MyD118, is first
cloned as a myeloid differentiation primary response
gene. It can be induced in the absence of protein synthesis
following treatment of M1 myeloblastic leukemia cells
with differentiation inducers[34], suggesting that
GADD45B play a role in hematopoiesis. KITLG is a pleio-
tropic factor that acts in utero in germ cell and neural cell
development, and hematopoiesis[35]. Accordingly,
Table 1: Identification of significantly changed molecular pathways by mappfinder analysis of the significantly altered genes in both 
transient overexpression and transient knockdown of the ZNF191 gene.
GOID Pathway Name/GO Term NO. genes % Changed Z-score
Up-regulated in overexpression and down-regulated in KD
43549 regulation of kinase activity 12 60 2.73
45859 regulation of protein kinase activity 12 60 2.73
165 MAPKKK cascade 8 66.7 2.60
51338 regulation of transferase activity 12 57.1 2.51
65008 regulation of biological quality 15 53.6 2.51
22402 cell cycle process 21 47.7 2.32
1525 angiogenesis 8 61.5 2.31
6952 defense response 13 52 2.19
6508 proteolysis 12 52.2 2.12
48514 blood vessel morphogenesis 8 57.1 2.04
7264 small GTPase mediated signal transduction 10 52.6 1.96
5515 protein binding 108 36.9 2.38
5525 GTP binding 9 60 2.36
30246 carbohydrate binding 10 55.6 2.18
19001 guanyl nucleotide binding 9 56.3 2.11
5783 endoplasmic reticulum 15 48.4 2.01
Down-regulated in overexpression and up-regulated in KD
6066 alcohol metabolic process 14 100 2.56
45449 regulation of transcription 95 77.9 2.45
9719 response to endogenous stimulus 17 94.4 2.40
6974 response to DNA damage stimulus 17 94.4 2.40
19219 regulation of nucleobase\, nucleoside\, nucleotide and nucleic acid metabolic process 95 77.2 2.30
7420 brain development 11 100 2.27
6355 regulation of transcription\, DNA-dependent 89 77.4 2.25
6350 transcription 96 76.8 2.21
3735 structural constituent of ribosome 15 100 2.65
46872 metal ion binding 153 75.7 2.63
43167 ion binding 154 75.1 2.43
43169 cation binding 140 75.3 2.32
3676 nucleic acid binding 129 75.4 2.25
46914 transition metal ion binding 103 76.3 2.17
35091 phosphoinositide binding 10 100 2.16
8270 zinc ion binding 94 76.4 2.09
4930 G-protein coupled receptor activity 9 100 2.05
16023 cytoplasmic membrane-bound vesicle 11 100 2.27
5830 cytosolic ribosome (sensu Eukaryota) 11 100 2.27
5578 proteinaceous extracellular matrix 23 88.5 2.23
31012 extracellular matrix 23 88.5 2.23
5840 ribosome 15 93.8 2.20
5842 cytosolic large ribosomal subunit (sensu Eukaryota) 10 100 2.16
15934 large ribosomal subunit 10 100 2.16
44420 extracellular matrix part 9 100 2.05BMC Genomics 2009, 10:241 http://www.biomedcentral.com/1471-2164/10/241
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Table 2: List of genes involved in the signal pathways
Fold change
Gene symbol ProbeName GenBank Description Overexpression Knockdown
Regulation of kinase activity
RB1 A_23_P204850 NM_000321 Retinoblastoma 1 (including osteosarcoma) 0.74 1.53
GADD45B A_23_P142506 NM_015675 Growth arrest and DNA-damage-inducible, beta 1.45 0.68
PKIA A_23_P31765 NM_006823 Protein kinase (cAMP-dependent, catalytic) 
inhibitor alpha
0.68 1.41
TIZ/ZNF675 A_24_P931755 D70835 TRAF6-inhibitory zinc finger protein 0.71 1.38
SPRY4 A_24_P269062 NM_030964 Sprouty homolog 4 (Drosophila) 2.12 0.57
DUSP6 A_23_P139704 NM_001946 Dual specificity phosphatase 6 1.56 0.74
RGS4 A_23_P200737 BC000737 Regulator of G-protein signalling 4 1.83 0.65
SPRED2 A_32_P225854 NM_181784 Sprouty-related, EVH1 domain containing 2 1.52 0.72
NRG1 A_23_P315815 NM_004495 Neuregulin 1 1.51 0.74
ZAK/MLTK_HUMAN A_23_P318300 NM_133646 Sterile alpha motif and leucine zipper containing 
kinase AZK
0.69 1.56
EDN1 A_23_P214821 NM_001955 Endothelin 1 2.33 0.49
PRKD3 A_24_P165656 NM_005813 Protein kinase D3 0.74 1.56
KITLG A_24_P133253 NM_000899 KIT ligand 0.68 1.51
C1QTNF6 A_24_P211565 NM_031910 C1q and tumor necrosis factor related protein 6 0.47 1.54
C5 A_23_P71855 NM_001735 Complement component 5 0.42 2.62
MAP4K5 A_23_P205646 BC036013 Mitogen-activated protein kinase kinase kinase 
kinase 5
0.74 1.39
CCNA1 A_23_P48414 NM_003914 Cyclin A1 2.51 0.54
CDKN2B A_24_P360674 NM_078487 Cyclin-dependent kinase inhibitor 2B 
(p15, inhibits CDK4)
1.81 0.71
CKS1B A_32_P175864 BG205572 CDC28 protein kinase regulatory subunit 1B 1.45 0.64
SERTAD1 A_23_P218463 NM_013376 SERTA domain containing 1 1.51 0.75
Angiogenesis
CEACAM1 A_24_P382319 NM_001712 Carcinoembryonic antigen-related cell adhesion 
molecule 1 (biliary glycoprotein)
0.60 1.78
COL18A1 A_23_P211212 NM_030582 Collagen, type XVIII, alpha 1 0.74 0.66
CTGF A_23_P19663 NM_001901 Connective tissue growth factor 3.88 0.24
MYH9 A_23_P57497 BC011915 Myosin, heavy polypeptide 9, non-muscle 1.34 0.75
NRP2 A_24_P50801 AF280546 Neuropilin 2 1.77 0.59
PLXDC1 A_23_P3911 BC036059 Plexin domain containing 1 0.63 1.38
VEGF A_23_P70398 NM_003376 Vascular endothelial growth factor 0.75 1.31
CXCL12 A_23_P202448 U19495 Chemokine 
(C-X-C motif) ligand 12 (stromal cell-derived 
factor 1)
0.73 1.37
CYR61 A_23_P46426 Z97068 Cysteine-rich, angiogenic inducer, 61 1.74 0.44
EDN1 A_23_P214821 NM_001955 Endothelin 1 2.33 0.49
SEMA5A A_23_P213415 NM_003966 Sema domain, seven thrombospondin repeats 
(type 1 and type 1-like), transmembrane domain 
(TM) and sh
0.28 2.26
IL17F A_23_P167882 NM_052872 Interleukin 17F 1.78 2.01
RUNX1 A_24_P34155 X90980 Runt-related transcription factor 1 
(acute myeloid leukemia 1; aml1 oncogene)
1.48 0.74
THBS1 A_23_P206212 X04665 Thrombospondin 1 1.97 0.59
Brain development
APAF1 A_23_P36611 NM_181861 Apoptotic protease activating factor 0.58 1.36
ATM A_23_P35916 NM_000051 Ataxia telangiectasia mutated 
(includes complementation groups A, C and D)
0.63 1.35
CXCL12 A_23_P202448 U19495 Chemokine 
(C-X-C motif) ligand 12 (stromal cell-derived 
factor 1)
0.73 1.37
SEPP1 A_23_P121926 NM_005410 Selenoprotein P, plasma, 1 0.66 1.36
SMARCA1 A_23_P44244 NM_003069 SWI/SNF related, matrix associated, actin 
dependent regulator of chromatin, subfamily a, 
member 1
0.43 1.40
ATRX A_24_P348660 NM_000489 Alpha thalassemia/mental retardation syndrome 
X-linked (RAD54 homolog, S. cerevisiae)
0.60 1.49
NOTCH3 A_32_P42895 A_32_P42895 Notch homolog 3 (Drosophila) 0.68 1.46BMC Genomics 2009, 10:241 http://www.biomedcentral.com/1471-2164/10/241
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ZNF191 has been isolated from bone marrow and promy-
elocytic leukemia cell lines [26]. These data infer that
ZNF191 may play a role in hematopoiesis.
Angiogenesis was another pathway markedly affected by
ZNF191 (Z-score 2.31). As shown in Figure 4, CTGF,
CYR61, EDN1, MYH9, NRP2, RUNX1, THBS1 were up-
regulated in the ZNF191-overexpressed cells, and down-
regulated in the knockdown cells. In addition, CEACAM1,
PLXDC1, CXCL12, SEMA5A and VEGF were down-regu-
lated in the ZNF191-overexpressed cells, and up-regulated
in the knockdown cells. Angiogenesis, the growth of new
blood vessels, is required for a variety of normal prolifer-
ative processes. Furthermore, angiogenesis is well estab-
lished as also playing an important role in neoplastic
growth and metastasis. VEGF is a potent stimulator of
angiogenesis. ZNF191 has been reported to be up-regu-
lated in angiogenic tumor nodules where VEGF expres-
sion is significantly decreased compared with
preangiogenic nodules[36]. In this study, our result in
HEK293 cells is consistent with the findings that in
human breast carcinoma cells overexpression of ZNF191
PRKG1 A_23_P136041 NM_006258 Protein kinase, cGMP-dependent, type I 0.43 1.34
ATP7A A_23_P217737 NM_000052 ATPase, Cu++ transporting, alpha polypeptide 
(Menkes syndrome)
0.48 1.52
FOXP2 A_24_P16559 AF467257 forkhead box P2 0.67 1.40
CEP290 A_23_P36865 AB002371 Centrosome protein cep290 0.70 1.43
Response to DNA damage stimulus
ZAK/NP_598407.1 A_23_P318300 NM_133646 Sterile alpha motif and leucine zipper containing 
kinase AZK
0.69 1.56
BRCA1 A_23_P207400 NM_007294 Breast cancer 1, early onset 0.71 1.3
ATM A_23_P35916 NM_000051 Ataxia telangiectasia mutated 
(includes complementation groups A, C and D)
0.63 1.35
ATRX A_24_P348660 NM_000489 Alpha thalassemia/mental retardation syndrome 
X-linked (RAD54 homolog, S. cerevisiae)
0.60 1.49
BRCA2 A_23_P99452 NM_000059 Breast cancer 2, early onset 0.62 1.3
BTG2 A_23_P62901 NM_006763 BTG family, member 2 0.72 1.35
Q6P2G2_HUMAN A_24_P361457 NM_173627 Hypothetical protein FLJ35220 (FLJ35220) 0.63 1.49
RBM14 A_23_P161644 NM_032886 RNA-binding motif protein 14 0.62 1.47
MLH3 A_24_P61520 NM_014381 MutL homolog 3 (E. coli) 0.59 1.45
N4BP2_HUMAN A_24_P222114 AK001542 Nedd4 binding protein 2 0.52 1.47
PMS1 A_23_P40059 NM_000534 PMS1 postmeiotic segregation increased 1 
(S. cerevisiae)
0.65 1.34
Table 2: List of genes involved in the signal pathways (Continued)
Gene list involved in the regulation of kinase activity pathway generated by GenMAPP Figure 3
Gene list involved in the regulation of kinase activity pathway generated by GenMAPP. The color on the left side 
of gene box illustrates the gene changes by ZNF191 overexpression; the color on the right indicates the gene changes by 
siRNA-mediated knockdown of ZNF191. Red and green indicates up-regulated and down-regulated in ZNF191 overexpression 
experiment, respectively. Yellow and blue indicates up-regulated and down-regulated in siRNA experiment, respectively. Grey 
indicates that selection criteria were not met but the gene was represented in the array. White boxes indicate that the gene 
was not present in the chip.BMC Genomics 2009, 10:241 http://www.biomedcentral.com/1471-2164/10/241
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results in a significant down-regulation of VEGF, whereas
silencing of ZNF191 with small interfering RNA leads to
increased VEGF expression as well as the same inverse cor-
relation between ZNF191 and VEGF observed in malig-
nant tissues from human colon and breast biopsies [36].
In addition, thrombospondin-1 (THBS1/TSP-1) has been
shown to inhibit angiogenesis through direct effects on
endothelial cell migration and survival, and through
effects on vascular endothelial cell growth factor bioavail-
ability. Aside from the inhibitory activity of angiogenesis,
THBS1 also suppresses tumor growth by activating trans-
forming growth factor beta and affects tumor cell function
through interaction with cell surface receptors and regula-
tion of extracellular proteases[37]. The data in this study
revealed that overexpression of ZNF191 resulted in a sig-
nificant up-regulation of THBS1, whereas silencing of
ZNF191 led to decreased THBS1 expression in HEK293
cells. Taken together, these data suggest that ZNF191 may
participate in negative regulation of angiogenesis. Further-
more, BMPR2 is overexpressed in the majority of human
lung carcinomas independent of cell type[38,39]. PDGFR
expression in colorectal cancer significantly correlates
with lymphatic dissemination[40]. MYO6 (myosin VI) is
critical in maintaining the malignant properties of the
majority of human prostate cancers diagnosed today[41].
The finding that overexpression of ZNF191 significantly
down-regulated  BMPR2, PDGFR and  MYO6, whereas
silencing of ZNF191 increased BMPR2, PDGFR and MYO6
expression suggests a tumor suppressor role for ZNF191
in human cancers.
The response to DNA damage node was significantly
affected (Z-score 2.4), mostly due to the regulation of
BRCA1, BRCA2, ATM, BTG2 and ATRX (Figure 5). The
most obvious explanation for this induction was that it
was related to initiation of DNA replication. Indeed, DNA
repair function is complementary to DNA replication, as
the latter process is not error-free and produces mis-
matches that need to be repaired. However, we reported
here that overexpression or elimination of ZNF191
Gene list involved in the angiogenesis pathway generated by GenMAPP Figure 4
Gene list involved in the angiogenesis pathway generated by GenMAPP. The color on the left side of gene box illus-
trates the gene changes by ZNF191 overexpression; the color on the right indicates the gene changes by siRNA-mediated 
knockdown of ZNF191. Red and green indicates up-regulated and down-regulated in ZNF191 overexpression experiment, 
respectively. Yellow and blue indicates up-regulated and down-regulated in siRNA experiment, respectively. Grey indicates 
that selection criteria were not met but the gene was represented in the array. White boxes indicate that the gene was not 
present in the chip.BMC Genomics 2009, 10:241 http://www.biomedcentral.com/1471-2164/10/241
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Gene list involved in the response to DNA damage stimulus pathway generated by GenMAPP Figure 5
Gene list involved in the response to DNA damage stimulus pathway generated by GenMAPP. The color on the 
left side of gene box illustrates the gene changes by ZNF191 overexpression; the color on the right indicates the gene changes 
by siRNA-mediated knockdown of ZNF191. Red and green indicates up-regulated and down-regulated in ZNF191 overexpres-
sion experiment, respectively. Yellow and blue indicates up-regulated and down-regulated in siRNA experiment, respectively. 
Grey indicates that selection criteria were not met but the gene was represented in the array. White boxes indicate that the 
gene was not present in the chip.
Gene list involved in the brain development pathway generated by GenMAPP Figure 6
Gene list involved in the brain development pathway generated by GenMAPP. The color on the left side of gene 
box illustrates the gene changes by ZNF191 overexpression; the color on the right indicates the gene changes by siRNA-medi-
ated knockdown of ZNF191. Red and green indicates up-regulated and down-regulated in ZNF191 overexpression experiment, 
respectively. Yellow and blue indicates up-regulated and down-regulated in siRNA experiment, respectively. Grey indicates 
that selection criteria were not met but the gene was represented in the array. White boxes indicate that the gene was not 
present in the chip.BMC Genomics 2009, 10:241 http://www.biomedcentral.com/1471-2164/10/241
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affected the upstream regulators of the DNA damage path-
way, such as ATM, ATRX, BRCA2 and BTG2. These data
suggest that ZNF191 may be involved in the control of
DNA damage response in addition to the regulation of
DNA replication and concurrent DNA repair. Microarray
and real-time PCR showed that RB1, ATM, ATRX and
BRCA1 genes were down-regulated in the ZNF191-overex-
pressed cells (Figure 7). Accordingly, RB1 knockdown by
siRNA caused the down-regulation of ATM, ATRX and
BRCA1[42].  RB1  mRNA level was down-regulated in
MCF-7 breast carcinoma cells by the overexpression of
ZNF191 (data not published).
Mice Zfp191 transcript is detected early during embryo-
genesis in ectodermal, endodermal, mesodermal and
extra-embryonic tissues. It is particularly observed in the
developing central nervous system (CNS)[43]. In rat,
ZNF191 mRNA is present at high levels in total embryonic
head, and abundant in catecholaminergic tissues includ-
ing substantia nigra, hypothalamus and olfactory bulb as
well as peripheral catecholaminergic tissue adrenal
medulla[27]. In human, ZNF191  transcript is also
detected in brain[27]. These studies demonstrate an
important role of ZNF191 in brain development. Interest-
ingly, in support with previous studies, our results showed
a node affected by ZNF191 was the brain development
node (Z-score 2.27). 11 genes (ATP7A, FOXP2, APAF1,
ATM, CXCL12, SEPP1, SMARCA1, ATRX, NOTCH3,
PRKG1, and CEP290) down-regulated in the ZNF191-
overexpressed cells and up-regulated in the ZNF191
knockdown cells (Figure 6). The human copper-transport-
ing ATP7A is essential for dietary copper uptake, normal
development and function of the CNS, and regulation of
copper homeostasis in the body[44]. In addition, studies
on Alzheimer's disease (AD) suggest an important role for
copper in the brain, with some AD therapies focusing on
mobilising copper in AD brains[45]. The transport of cop-
per into the brain is complex and involves numerous play-
ers, including amyloid precursor protein, A beta peptide
and cholesterol[45,46]. Interestingly, in a yeast two-
hybrid experiment using the SCAN domain of ZNF191 as
bait, we identified that the zinc finger transcription factor
ZNF191 can interact with NAE1(NEDD8 activating
enzyme E1 subunit 1; amyloid beta precursor protein
binding protein 1, 59 kDa) (unpublished data). FOXP2
mutations in humans are associated with a disorder that
affects both the comprehension of language and its pro-
duction, speech[47]. ZNF191 transcript was abundant in
the mesencephalon, a structure that contains the major rat
embryonic catecholaminergic tissues[27]. Accordingly,
Quantitative real-time PCR confirmation of the microarray results Figure 7
Quantitative real-time PCR confirmation of the microarray results. qPCR was performed on 21 genes that showed 
differential regulation in response to ZNF191 overexpression and knockdown by siRNA. Gene expression levels are shown as 
the mean normalized to the expression of the housekeeping gene GAPDH. Each sample was measured in triplicate. Columns, 
mean of three independent experiments; bars, SD. Comparison of fold change produced by microarray with relative expression 
ratio obtained from real-time PCR, with good concordance.BMC Genomics 2009, 10:241 http://www.biomedcentral.com/1471-2164/10/241
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ZNF191 can specifically interact with the widespread
TCAT motif which constitutes the HUMTH01 microsatel-
lite in the tyrosine hydroxylase (TH) gene (encoding the
rate-limiting enzyme in the synthesis of catecho-
lamines)[27]. Allelic variations of HUMTH01 are known
to have a quantitative silencing effect on TH gene expres-
sion and to correlate with quantitative and qualitative
changes in the binding by ZNF191[27]. In this study,
overexpression of ZNF191 resulted in a significant down-
regulation of TH, whereas knockdown of ZNF191 resulted
in a non-significant change of TH level. The expression
level of the TH gene is indistinguishable between the wild-
type, Zfp191+/-, and Zfp191-/- mice[32]. These data suggest
that other genes may compensate at least in part for the
loss of ZNF191 activity, ameliorating the effect of the
ZNF191 knockdown. Taken together, these data suggest
that ZNF191 may be involved in the brain development
and the neuropsychiatric diseases.
We have to point out that in the knockdown experiments
we can only deduce the level of ZNF191 protein by the
level of mRNA of ZNF191 because no antibody against
the ZNF191 factor is commercially available and the turn-
over of the protein is still unknown. So there is no mean
to ascertain whether and when the ZNF191 protein is
reduced significantly. In addition, in this study HEK293
cells were used as a cellular model to identify genes mod-
ified by the ZNF191 transcription factor. Some other cells
could give at least partially over transcriptome modifica-
tion. Furthermore, the transcriptional response found
upon alteration of ZNF191 levels does not necessarily
imply that this transcription factor regulates the differen-
tially expressed genes. Many of the observed changes
could be downstream and not direct effects of ZNF191
regulation. A proof of direct regulation would require a
promoter analysis or some kind of DNA-protein binding
experiment or in silico analysis.
Conclusion
We applied overexpression and siRNA-mediated gene
silencing coupled with microarray screening and system-
atic pathway analysis to obtain insights into the pathways
controlled by the target genes. We found that ZNF191 reg-
ulated the expression of a large group of genes involved in
regulation of kinase activity, angiogenesis, brain develop-
ment and response to DNA damage. Our analysis reveals
that ZNF191 is a pleiotropic factor in hematopoiesis,
brain development, and human cancers. Our approach
can be used in functional genomics to elucidate the role of
other transcription factors.
Methods
Cell culture and transfection
HEK-293 cells were cultured in DMEM medium supple-
mented with 10% fetal bovine serum (FBS) in an atmos-
phere of 95% air, 5% CO2 at 37°C. Cells were plated into
60 mm dishes without antibiotics 24 h prior to transfec-
tion. The recombinant plasmids, or control vector, were
transfected into HEK-293 cells using Lipofectamine 2000
reagents according to the manufacturer's instructions.
HEK-293 cells transfected with each cDNA or siRNA were
lysed after 24 h or 48 h to isolate total RNA.
Plasmids
The cDNA clone of ZNF191 was provided by Prof. Long Y.
(Genetics Institute, Fudan University, Shanghai, China).
ZNF191 cDNA was cloned into pcDNA3 (Invitrogen) by
using HindIII and XhoI restriction sites. The cloning was
verified by DNA sequencing. The hairpin siRNA expres-
sion vectors against ZNF191 were previously generated
[32].
RNA isolation
Total RNA was extracted using the Trizol reagent (Invitro-
gen) and purified on RNeasy columns (Qiagen). The
amount and quality of RNA preparations were evaluated
on the Agilent 2100 Bioanalyzer with RNA6000 Nano
Reagents and Supplies (Agilent).
Microarray hybridization
Five hundred nanograms of RNA were reverse-transcribed
to cDNA during which process a T7 sequences was intro-
duced into cDNA. T7 RNA polymerase-driven RNA syn-
thesis was used for the preparation and labeling of cRNA
with Cy3 (the reference sample) and Cy5 (the treated
sample), respectively. A Qiagen RNeasy Mini Kit (Qiagen
Inc., Valencia, CA) was used to purify fluorescent cRNA
probes. An equal amount (1 g) of Cy3 and Cy5 labeled
probes were mixed and used for hybridization on one Agi-
lent 4 × 44 K Human Whole-Genome 60-mer oligonucle-
otide microarrays(Agilent Techonologies Inc., Santa
Clara, CA) following the protocol provided by the manu-
facturer.
Data acquisition and processing
Microarrays were scanned with a dynamic autofocus
microarray scanner (Agilent dual laser DNA microarray
scanner, Agilent technologies, Palo Alto, CA, USA), using
Agilent-provided parameters (Red and Green PMT were
each set at 100%, and scan resolution was set to 10 m).
The Feature Extraction Software v7.5 (Agilent Technolo-
gies) was used to extract and analyse the signals. Agilent-
provided settings were used except for subtraction of the
local background and adjustment of the global back-
ground. Poor quality features that were either saturated in
the two channels (50% of pixels > saturation threshold)
or non-uniform were flagged. Only those features with a
signal-to-noise ratio (SNR) of up to 2.6 in at least one
channel and significantly different from the local back-
ground (two sided Student's t-test < 0.05) were used forBMC Genomics 2009, 10:241 http://www.biomedcentral.com/1471-2164/10/241
Page 12 of 14
(page number not for citation purposes)
further analysis. The mean signal ratio of the two fluores-
cent intensities (Cy-5 treated cRNA/Cy-3 reference cRNA)
is expressed as a logarithm (base 2), providing a relative
quantitative gene expression measurement between two
samples. For subsequent analysis, we used mean-centered
log2 of the normalized (linear & lowess method) sample:
reference ratio. Microarray data meeting a criterion (> 1.2-
fold change, Flag = 0, S/N > 2.6 and pValueLogRatio <
0.05) were considered to be significant and used for fur-
ther analysis.
Pathway analysis
The GeneMapp and MappFinder software packages http:/
/www.genmapp.org were used for pathway analysis of the
significantly altered genes identified in both transient
overexpression and transient knockdown of the
ZNF191gene. The MAPPFinder works with GenMAPP and
uses the annotations from the Gene Ontology (GO) Con-
sortium to identify global biological trends in gene
expression data. MAPPFinder relates microarray data to
each term in the GO hierarchy, calculates the percentage
of genes changed within each GO term, and generates a
gene expression profile at the level of biological processes,
cellular components, and molecular functions that allows
for identification of specific biological pathways. MAPP-
Finder then calculates the total number of genes changed
within a "parent GO term" and all of its "children" (local
MAPPs) using Fisher's exact test. The results are expressed
as a "z score" for a particular pathway, and values greater
than 2 were considered to be significant. GenMAPP was
also used to view and analyze microarray data on biolog-
ical pathways[33].
Quantitative real-time PCR
Twenty-one interested genes were selected for validation
by real time PCR. cDNAs were prepared from 1 g of total
RNA using AMV reverse transcriptase (Promega) and ran-
dom primers according to the manufacturer's protocol.
For each gene, PCR reactions were run three times on one
sample. PCR was performed on Chromo4 Multicolor
Real-Time Detection System (Bio-Rad, Inc.) in 20 l reac-
tions by using the SYBR™ Green PCR Master Mix
(TaKaRa). The reaction was repeated for 40 cycles; each
cycle consisted of denaturing at 95°C for 15 s, annealing
and synthesis at 60°C for 1 min as per manufacturer's
instructions. The relative amounts of transcript of the
tested genes were normalized by GAPDH endogenous
control primers set. The average ratios of relative amounts
of transcript in the ZNF191-overexpressed cells or
ZNF191 knockdown cells versus empty vector cells from
three replicate runs were calculated. Quantitative values
are obtained from the cycle number (Ct value) using Opti-
con Monitor 3.1 (Bio-Rad) according to the manufac-
turer's instructions. The threshold cycle (CT) values were
averaged from the values obtained from each reaction,
and each gene was normalized to GAPDH level. Each gene
of interest and GAPDH were tested in triplicates to deter-
mine the Ct-difference. These Ct values were averaged and
the difference between the GAPDH Ct (Avg) and the gene
of interest Ct (Avg) was calculated (Ct-diff). The fold
change was calculated by the 2-CT, where CT = (CT-
treated-CT-contrl). CT-treated means the signal of an indi-
vidual gene expressed in ZNF191-overexpressed or knock-
down samples, while CT-control means the signal of the
same gene expressed in control samples. The relative
expression of the gene of interest was analyzed using the
2-CT method [48]. Because SYBR Green binding is not
sequence specific, careful design and validation of each
primer pair, as well as cautious manipulation of RNA were
undertaken to ensure that only target gene sequence-spe-
cific, non-genomic products were amplified by real-time
PCR. To achieve this, primers were designed to either span
or flank introns. PCR primers are listed in Additional file
4. A dissociation curve analysis was performed at the end
of the amplification process in order to verify the specifi-
city of the PCR products. The same PCR products were
also evaluated by agarose gel electrophoresis. Data analy-
sis and graphics were the results (mean ± SEM) of three
different experiments.
Semi-quantitative PCR
Semi-quantitative PCRs were performed with Zfp191 spe-
cific primers (forward: 5'-ATCAGCGGTGGCCACATCAA-
3' and reverse: 5'-GATGGGCCCAACCCAATATAT-3'),
which yielded 481 bp products. To serve as an internal
control, a 381 bp fragment of the glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) cDNA was co-amplified
with primers (forward, 5'-AACTTTGGTATCGT-
GGAAGGA-3'; reverse, 5'-GGAGGAGTGGGTGTCGCTGT-
3'). The PCRs were carried out for 25–40 cycles at 94°C
for 1 min, 55°C for 1 min, and 72°C for 1 min with a final
extension of 5 min at 72°C. All RT-PCR experiments were
repeated at least twice and the products were electro-
phoresed on 1.5% agarose gels containing ethidium bro-
mide.
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